T cell responses during HBV and HCV infections: similar but not quite the same?

Curr Opin Virol. 2021 Dec:51:80-86. doi: 10.1016/j.coviro.2021.08.011. Epub 2021 Oct 4.

Abstract

The hepatitis B and C viruses persist by evasion of T cell immunity. Persistence depends upon premature failure of CD4+ T cell help and loss of CD8+ T cell control because of epitope mutational escape and/or functional exhaustion. Powerful new immunological and transcriptomic tools provide insight into the mechanisms of T cell silencing by HBV and HCV. Similarities are apparent, including dysregulated expression of common inhibitory/immune checkpoint receptors and transcription factors. There are also differences. T cell exhaustion is uniform in HCV infection, but varies in HBV infection depending on disease stage and/or protein target. Here, we review recent advances defining similarities and differences in T cell evasion by HBV and HCV, and the potential for reversal following antiviral therapy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Hepacivirus / drug effects
  • Hepacivirus / immunology*
  • Hepatitis B / drug therapy
  • Hepatitis B / genetics
  • Hepatitis B / immunology*
  • Hepatitis B / virology
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / immunology*
  • Hepatitis C / drug therapy
  • Hepatitis C / genetics
  • Hepatitis C / immunology*
  • Hepatitis C / virology
  • Humans
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism